[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:dna-index":3},{"name":4,"total":5,"recruiting":5,"trials":6},"DNA index",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05489887","Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma",[11],"Phase 2","RECRUITING","2026-08-26T02:19:16.454910Z","2026-07-05T05:32:16.806484Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT02559778","Pediatric Precision Laboratory Advanced Neuroblastoma Therapy",[11],"2026-08-26T02:16:24.970704Z","2026-05-05T02:43:29.219995Z"]